Reciprocal relationships between abnormal metabolic parameters and endothelial dysfunction.
about
Muscle contraction, but not insulin, increases microvascular blood volume in the presence of free fatty acid-induced insulin resistance.Cytochrome P450 metabolites of arachidonic acid play a role in the enhanced cardiac dysfunction in diabetic rats following ischaemic reperfusion injury.Silent Partner in Blood Vessel Homeostasis? Pervasive Role of Nitric Oxide in Vascular Disease.Distinct vascular and metabolic effects of different classes of anti-hypertensive drugs.Simvastatin improves flow-mediated dilation but reduces adiponectin levels and insulin sensitivity in hypercholesterolemic patientsCombination therapy for treatment or prevention of atherosclerosis: focus on the lipid-RAAS interactionSulfation of 25-hydroxycholesterol by SULT2B1b decreases cellular lipids via the LXR/SREBP-1c signaling pathway in human aortic endothelial cellsContributions of dysglycaemia, obesity, and insulin resistance to impaired endothelium-dependent vasodilation in humans.Lipoprotein subclass abnormalities and incident hypertension in initially healthy womenAdiponectin: an adipokine with protective features against metabolic syndrome.Differential metabolic actions of specific statins: clinical and therapeutic considerationsOverexpression of steroidogenic acute regulatory protein in rat aortic endothelial cells attenuates palmitic acid-induced inflammation and reduction in nitric oxide bioavailabilityThe role of abnormal metabolic conditions on arterial stiffness in healthy subjects with no drug treatmentDrug discovery in the metabolic syndrome: context and some recent developments.Rosuvastatin does not affect fasting glucose, insulin resistance, or adiponectin in patients with mild to moderate hypertensionVascular and metabolic effects of treatment of combined hyperlipidemia: focus on statins and fibrates.Combination pravastatin and valsartan treatment has additive beneficial effects to simultaneously improve both metabolic and cardiovascular phenotypes beyond that of monotherapy with either drug in patients with primary hypercholesterolemia.Leptin and cardiovascular disease: response to therapeutic interventionsDifferential metabolic effects of pravastatin and simvastatin in hypercholesterolemic patients.The effect of telmisartan on endothelial function and arterial stiffness in patients with essential hypertension.Health benefits of walnut polyphenols: An exploration beyond their lipid profile.Walnut extract (Juglans regia L.) and its component ellagic acid exhibit anti-inflammatory activity in human aorta endothelial cells and osteoblastic activity in the cell line KS483.Deletion of interleukin 1 receptor-associated kinase 1 (Irak1) improves glucose tolerance primarily by increasing insulin sensitivity in skeletal muscle.Chios mastic gum extract and isolated phytosterol tirucallol exhibit anti-inflammatory activity in human aortic endothelial cells.Beneficial effects of rosiglitazone on novel cardiovascular risk factors in patients with Type 2 diabetes mellitus.
P2860
Q30434274-08723270-1DC2-406C-87B1-8951310E4EADQ33700011-434DD3EE-ABB2-48AB-9B97-2F8814636231Q33760484-1D0B3115-CE8D-404D-8A4C-6F53C84FE711Q33821236-7E21AE00-D02D-484C-84DB-8021E85650B0Q34177113-E08E87E0-F277-4070-B1DA-3611703E3F6EQ34231611-12F1682F-8CC6-4841-9402-320966908699Q34542885-C2520496-9FEE-4029-8564-246580B5CA17Q34960630-6FC4CFB9-C28E-4DDF-B36D-FC1BC5620FFDQ35157585-A8819938-D63E-4EBD-99C0-C7472578F653Q35763433-18F44DC0-19DF-43F3-A968-E10142840EA5Q36406951-992251F5-F085-4197-8BA0-8EE5B616F099Q36510295-51953144-138A-48DA-A0C3-B10F7E0492F3Q36588149-F41A53A2-59DD-4241-BC53-3E7DD734A085Q36822448-9B190589-5861-4F0F-96B2-CE5F1E31524DQ36837587-B8029EC9-A925-441A-8E75-A7C658AEB2DAQ36894180-A74581D9-AE7D-4DD5-AF6F-7421973B74BEQ37193394-DC660CC9-8C90-429B-B6A8-FDCDD95C2FFDQ37198354-701E970D-325A-4D0A-B6CD-D974000FA581Q37362218-F45F5359-5FB7-4983-8791-A7A0F4A855BEQ37408666-B5C8199D-2802-4058-AC91-699D34099E39Q38682113-AD04A2BA-7FDD-4781-9736-EF6894AFA1B1Q40072086-6B9B0B75-5CD7-48C6-8291-F485B8BCDE71Q43993044-E722E95A-E5F2-4B3D-B168-AF04CA6CB321Q44631487-894C42F5-6D89-44A7-8B05-33B60238DD05Q46728070-57BC36E1-A2DF-4FBC-9133-F5580548B575
P2860
Reciprocal relationships between abnormal metabolic parameters and endothelial dysfunction.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Reciprocal relationships betwe ...... s and endothelial dysfunction.
@ast
Reciprocal relationships betwe ...... s and endothelial dysfunction.
@en
type
label
Reciprocal relationships betwe ...... s and endothelial dysfunction.
@ast
Reciprocal relationships betwe ...... s and endothelial dysfunction.
@en
prefLabel
Reciprocal relationships betwe ...... s and endothelial dysfunction.
@ast
Reciprocal relationships betwe ...... s and endothelial dysfunction.
@en
P1476
Reciprocal relationships betwe ...... rs and endothelial dysfunction
@en
P2093
Kwang Kon Koh
Seung Hwan Han
P356
10.1097/MOL.0B013E328012B627
P577
2007-02-01T00:00:00Z